Analysts See $0.70 EPS for MarineMax (HZO), Iguana Healthcare Management Has Increased Celgene (CELG) Position

July 7, 2017 - By Linda Rogers

Iguana Healthcare Management Llc increased Celgene Corp (CELG) stake by 6.67% reported in 2016Q4 SEC filing. Iguana Healthcare Management Llc acquired 5,000 shares as Celgene Corp (CELG)’s stock declined 3.49%. The Iguana Healthcare Management Llc holds 80,000 shares with $9.26M value, up from 75,000 last quarter. Celgene Corp now has $105.42B valuation. The stock decreased 0.94% or $1.25 during the last trading session, reaching $131.95. About shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since July 7, 2016 and is uptrending. It has outperformed by 0.30% the S&P500.

Analysts expect MarineMax Inc (NYSE:HZO) to report $0.70 EPS on July, 25.They anticipate $0.13 EPS change or 22.81% from last quarter’s $0.57 EPS. HZO’s profit would be $18.35M giving it 6.93 P/E if the $0.70 EPS is correct. After having $0.11 EPS previously, MarineMax Inc’s analysts see 536.36% EPS growth. The stock decreased 1.77% or $0.35 during the last trading session, reaching $19.4. About shares traded. MarineMax Inc (NYSE:HZO) has risen 12.03% since July 7, 2016 and is uptrending. It has underperformed by 4.67% the S&P500.

Among 23 analysts covering Celgene Corporation (NASDAQ:CELG), 18 have Buy rating, 0 Sell and 5 Hold. Therefore 78% are positive. Celgene Corporation had 51 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, November 9 by Standpoint Research. The firm has “Buy” rating given on Thursday, July 6 by Credit Suisse. The firm has “Neutral” rating by BTIG Research given on Friday, June 30. The stock has “Strong-Buy” rating by Raymond James on Tuesday, September 1. The stock has “Buy” rating by Jefferies on Wednesday, September 9. The rating was upgraded by BTIG Research to “Buy” on Thursday, August 4. Jefferies maintained the shares of CELG in report on Wednesday, October 5 with “Buy” rating. On Wednesday, June 1 the stock rating was downgraded by BTIG Research to “Neutral”. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Thursday, July 6 by Cantor Fitzgerald. The firm earned “Buy” rating on Friday, November 6 by Canaccord Genuity.

Investors sentiment decreased to 0.98 in 2016 Q4. Its down 0.13, from 1.11 in 2016Q3. It dropped, as 57 investors sold CELG shares while 470 reduced holdings. 116 funds opened positions while 398 raised stakes. 587.86 million shares or 1.69% more from 578.10 million shares in 2016Q3 were reported. Ascend Cap Limited Co invested 0.16% of its portfolio in Celgene Corporation (NASDAQ:CELG). Natl Asset Management Incorporated holds 0.35% in Celgene Corporation (NASDAQ:CELG) or 14,910 shares. The Ontario – Canada-based Guardian Cap LP has invested 0% in Celgene Corporation (NASDAQ:CELG). Ahl Partners Ltd Liability Partnership holds 2,340 shares or 0.01% of its portfolio. Miracle Mile Advisors Limited Liability Company has 0.05% invested in Celgene Corporation (NASDAQ:CELG) for 1,886 shares. Moreover, Cannell Peter B And has 6.9% invested in Celgene Corporation (NASDAQ:CELG). The New York-based Glg Ltd Co has invested 0.36% in Celgene Corporation (NASDAQ:CELG). Ims holds 0.8% or 6,435 shares. Everett Harris & Ca reported 4,120 shares. Bnp Paribas Inv Partners stated it has 871,055 shares. Point72 Asset Mngmt Lp reported 0.52% of its portfolio in Celgene Corporation (NASDAQ:CELG). Waddell & Reed Incorporated owns 2.39 million shares. Rockefeller Fin holds 15,399 shares or 0.04% of its portfolio. Argent Tru stated it has 0.58% in Celgene Corporation (NASDAQ:CELG). Novare Capital Limited Com owns 47,899 shares or 1.36% of their US portfolio.

Since February 27, 2017, it had 0 insider buys, and 6 selling transactions for $5.51 million activity. 14,033 shares valued at $1.74 million were sold by KAPLAN GILLA on Thursday, March 30. 9,250 shares were sold by CASEY MICHAEL D, worth $1.16 million on Saturday, June 17. $575,038 worth of Celgene Corporation (NASDAQ:CELG) shares were sold by VESSEY RUPERT. On Saturday, June 17 the insider Friedman Michael A sold $625,000.

Iguana Healthcare Management Llc decreased Zimmer Biomet Hldgs Inc (ZMH) stake by 35,000 shares to 50,000 valued at $5.16 million in 2016Q4. It also reduced Clovis Oncology Inc (NASDAQ:CLVS) stake by 250,000 shares and now owns 75,000 shares. Nuvasive Inc (NASDAQ:NUVA) was reduced too.

Investors sentiment increased to 1.4 in Q4 2016. Its up 0.04, from 1.36 in 2016Q3. It increased, as 14 investors sold MarineMax Inc shares while 41 reduced holdings. 29 funds opened positions while 48 raised stakes. 22.73 million shares or 6.30% less from 24.26 million shares in 2016Q3 were reported. Jacobs Levy Equity Mngmt Incorporated has 71,700 shares. Public Employees Retirement Association Of Colorado holds 0% or 8,648 shares. 43,000 are owned by Hancock Com. Rhumbline Advisers reported 45,943 shares. Metropolitan Life Insurance Communications has invested 0% in MarineMax Inc (NYSE:HZO). Clarivest Asset Mgmt Lc has 0.01% invested in MarineMax Inc (NYSE:HZO). Impala Asset Management Limited Liability Co reported 1.54% stake. Wells Fargo & Mn has 108,834 shares for 0% of their portfolio. Redwood Invests Ltd Liability owns 0.01% invested in MarineMax Inc (NYSE:HZO) for 5,379 shares. Gotham Asset Mngmt Ltd Company stated it has 0.01% of its portfolio in MarineMax Inc (NYSE:HZO). Axiom International Invsts Ltd Liability Co De accumulated 0.05% or 96,378 shares. 12,000 were accumulated by Yorktown Research. Mason Street Advisors Ltd Llc, a Wisconsin-based fund reported 5,394 shares. Dimensional Fund Advisors Limited Partnership has 2.18 million shares. Marshall Wace Limited Liability Partnership holds 0% or 21,147 shares in its portfolio.

Since February 21, 2017, it had 0 buys, and 2 sales for $1.57 million activity. MCGILL WILLIAM H JR sold $1.34 million worth of MarineMax Inc (NYSE:HZO) on Tuesday, February 21. McGill W Brett also sold $228,552 worth of MarineMax Inc (NYSE:HZO) on Wednesday, March 15.

MarineMax, Inc. is a recreational boat and yacht dealer in the United States. The company has market cap of $508.65 million. Through 56 retail locations in Alabama, California, Connecticut, Florida, Georgia, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Rhode Island, and Texas, the Company sold new and used recreational boats, including pleasure and fishing boats, as of September 30, 2016. It has a 19.57 P/E ratio. The Firm also sells related marine products, including engines, trailers, parts and accessories.

Among 6 analysts covering Marinemax (NYSE:HZO), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Marinemax had 7 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of MarineMax Inc (NYSE:HZO) has “Neutral” rating given on Wednesday, January 25 by Wedbush. The firm has “Buy” rating given on Thursday, December 3 by Craig Hallum. The firm has “Buy” rating given on Tuesday, August 18 by Longbow. The company was maintained on Monday, September 14 by Stephens. The firm has “Buy” rating by Citigroup given on Friday, February 10.